Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022 Read more
MALACHITE INNOVATIONS ANNOUNCES EXPANSION OF SENIOR LEADERSHIP TEAM AND ENGAGEMENT OF TWO NEW STRATEGIC ADVISORS Read more
IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages Read more
NFWF Announces $2.9 Million in Grants from the Monarch Butterfly and Pollinators Conservation Fund Read more